NCT07169786

Brief Summary

The aim of this study is to investigate the relationship between dietary patterns and the progression of chronic kidney disease (CKD) in patients with type 2 diabetes mellitus.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
32mo left

Started Oct 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress19%
Oct 2025Dec 2028

First Submitted

Initial submission to the registry

August 22, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 12, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

September 12, 2025

Status Verified

August 1, 2025

Enrollment Period

3 years

First QC Date

August 22, 2025

Last Update Submit

September 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the influence of dietary pattern on the progression of chronic kidney disease among patients with type 2 Diabetes Milletus

    Primary Outcomes Measures 1\. change in estimated glomerular filtration rate (eGFR) from baseline to 6 month using CKD-EPI formula mL/min/1.73 m² Time frame 6 month

    6 month

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged above 18 years with chronic kidney disease stages 1-4 and type 2 Diabetes Milletus

You may qualify if:

  • Adults aged above 18 years
  • Diagnosed with type 2 diabetes mellitus according to ADA criteria.
  • Diagnosed with chronic kidney disease stages 1-4 (eGFR 15-90 mL/min/1.73 m²) for at least 3 months.
  • Willing and able to provide informed consent

You may not qualify if:

  • Patients with end-stage renal disease (CKD stage 5 or on dialysis).
  • History of kidney transplantation.
  • Acute kidney injury within the past 3 months.
  • Pregnant or lactating women.
  • Patients with severe comorbid conditions (e.g., active malignancy, severe heart failure).
  • Use of medications known to significantly affect renal function (other than standard antihypertensive or antidiabetic therapy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Salah Abdelazeem Argoon

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
resident physician ,internal medicine

Study Record Dates

First Submitted

August 22, 2025

First Posted

September 12, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

September 12, 2025

Record last verified: 2025-08